Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings crawled time : 22:00 save search
AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
ANTX | $2.38 0.85% 0.84% 83K
|
|
| O: 0.31%
H: 4.64%
C: 0.62%
business year therapeutics financial results
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
IMNM | $14.64 -4.19% -4.37% 890K
|
Health Technology
|
| O: 0.04%
H: 0.86%
C: -3.33%
year update financial acquired results
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
NDRA | $0.248 -0.88% -0.89% 37K
|
Health Technology
|
| O: -2.26%
H: 2.92%
C: -27.66%
business life year update sciences financial results
Dyadic Reports 2023 Full Year Results and Recent Company Progress
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
MRVI 4 | $7.72 4.75% 4.53% 2.2M
|
Commercial Services
|
| O: 0.7%
H: 1.5%
C: 0.35%
DYAI 4 | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 0.61%
H: 5.49%
C: 1.83%
company year results
SCYNEXIS Reports Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-28 (Crawled : 22:00) - biospace.com/
SCYX | $1.53 6.25% 5.88% 150K
|
Health Technology
|
| O: -0.35%
H: 7.04%
C: 3.52%
year update financial results
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
Published: 2024-03-27 (Crawled : 22:00) - biospace.com/
MCK | $532.0 0.89% 0.0% 380K
|
Distribution Services
|
| O: 0.42%
H: 0.3%
C: 0.17%
corporation
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
ACET | News | $2.1 5.0% 4.76% 1.1M
|
Health Technology
|
| O: 1.03%
H: 4.57%
C: 3.05%
company year financial results
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
RLMD | $3.91 1.03% 1.02% 140K
|
Health Technology
|
| O: 0.0%
H: 5.8%
C: -2.72%
update therapeutics financial results
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
TIVC | $1.17 4.31% 6K
|
|
| O: 1.25%
H: 2.59%
C: -0.44%
conference report health financial results
Ecolab Schedules Webcast and Conference Call on April 30th
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
ECL | News | $219.66 0.16% 0.0% 720K
|
Process Industries
|
| O: 0.67%
H: 0.0%
C: -1.0%
conference ecolab
Syra Health To Discuss Fourth Quarter and Fiscal Year 2023 Financial Results
Published: 2024-03-19 (Crawled : 22:00) - biospace.com/
SYRA | $1.0 -1.96% -2.0% 59K
|
n/a
|
| O: -1.2%
H: 4.87%
C: 1.22%
health year financial results
Cerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
Published: 2024-03-05 (Crawled : 22:00) - biospace.com/
CERS | $1.67 -1.18% -1.2% 780K
|
Health Technology
|
| O: -0.94%
H: 0.95%
C: -5.24%
corporation financial results
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-05 (Crawled : 22:00) - biospace.com/
MRNS | $1.455 -1.36% -1.37% 2.9M
|
Health Technology
|
| O: 0.21%
H: 1.05%
C: -3.35%
business year update pharmaceuticals financial results
Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-03-04 (Crawled : 22:00) - biospace.com/
ATXS | $9.63 -1.74% -1.77% 750K
|
Manufacturing
|
| O: 0.67%
H: 0.46%
C: -5.44%
year update therapeutics financial results
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
Published: 2024-01-05 (Crawled : 22:00) - biospace.com/
ANGO | $6.035 -3.59% -3.73% 380K
|
Health Technology
|
| O: -19.48%
H: 2.0%
C: -0.48%
year financial
Bristol Myers Squibb to Report Results for Fourth Quarter 2023 on February 2, 2024
Published: 2023-12-15 (Crawled : 22:00) - biospace.com/
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.6%
H: 0.57%
C: -0.53%
report results
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results and Raises Full Year 2023 Financial Guidance
Published: 2023-10-23 (Crawled : 22:00) - biospace.com/
AMRX | $5.4 0.56% 0.56% 1.4M
|
Health Technology
|
| O: -1.44%
H: 3.51%
C: -1.75%
year financial results
Simulations Plus Announces Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
Published: 2023-10-11 (Crawled : 22:00) - biospace.com/
SLP | $45.94 2.09% 2.05% 110K
|
Technology Services
|
| O: 0.14%
H: 0.0%
C: -0.45%
conference year plus
AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023
Published: 2023-10-11 (Crawled : 22:00) - biospace.com/
ABCL | $3.985 -0.62% -0.63% 1.6M
|
|
| O: -0.44%
H: 1.06%
C: -2.44%
report financial results
Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
Published: 2023-09-19 (Crawled : 22:00) - biospace.com/
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: -0.31%
H: 0.96%
C: 0.91%
conference financial results
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.